CVS Health Settles Pricing Fight With Walmart 
 

CVS Health and Walmart settled their fight over the cost of filling prescriptions, averting a threatened split

 
Tesla to Slash More Jobs in Effort to Lower Model 3 Price 
 

Elon Musk's Tesla is cutting its full-time workforce by 7% as part of an effort to lower costs so the company can sell the Model 3 sedan at a lower price, the chief executive told employees.

 
Lilly's Sarcoma Drug Combo Proves Ineffective in Trials 
 

Eli Lilly & Co. said a study combining two drug treatments for patients with advanced sarcoma wasn't clinically beneficial.

 
Nissan Says Carlos Ghosn Received $8.9 Million in Improper Payments 
 

Nissan Motor and Mitsubishi Motors made a rare public statement outlining specific allegations against Carlos Ghosn, the former chairman of both companies.

 
M&A Heats Up for Battered Mining Companies 
 

Deals and activist campaigns at mining companies are picking up, but it may not be enough to rekindle investor enthusiasm for the group.

 
NGP Raises More Than $4 Billion for Oil-And-Gas Deals 
 

The Irving, Texas firm, in which Carlyle Group LP holds a stake, plans to close its latest flagship fund soon, said people familiar with the matter.

 
Malaysia's Finance Minister Wants Goldman's $7.5 Billion, Not an Apology 
 

Lim Guan Eng waved off an apology from Goldman Sachs Chief Executive David Solomon for the role of one its then-bankers in the scandal surrounding state investment fund 1MDB, saying it wasn't enough.

 
Drugmakers Raise Prices Amid Shortages, Recalls 
 

The increases can mean higher costs for pharmacies and patients on what are generally cheaper generic drugs. Drugmakers say the price increases reflect higher costs they have incurred to help fill supply voids.

 
Intel's Tough Act to Follow 
 

Rival TSMC has been making the chip maker's life difficult lately, so a small reprieve is welcome-even if it is to be short-lived, as Intel confronts a number of hurdles after a banner year.

 
Ryanair Warns on Profit as Fares Fall 
 

Ryanair lowered its full-year profit forecast blaming a 7% slip in winter fares and said unforeseen Brexit developments could lead to further cuts.

 
 

(END) Dow Jones Newswires

January 18, 2019 09:15 ET (14:15 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.